News | Heart Failure | December 16, 2021

First-Of-Its-Kind Medicare Advantage Plan Addresses Diabetics With Heart Failure

New York and Vermont plan is one of three plans in the country to offer free, level 3 cardiac rehab

First-Of-Its-Kind Medicare Advantage Plan Addresses Diabetics With Heart Failure. Getty images

Getty images


December 16, 2021 — MVP Health Care and The University of Vermont Health Network recently announced their joint Medicare Advantage Plan, called UVM Health Advantage, will offer older adults in Northern New York and Vermont support for their two biggest health concerns: heart disease and diabetes. The plan provides 3 months of free medically tailored meals for those diagnosed with congestive heart failure, up to 36 free rides to or from medical appointments, a digital blood pressure cuff and pulse oximeter, low-cost orthotics and diabetic shoes, and more. Members of UVM Health Advantage will also have access to MVP’s vast network of physicians across Vermont and New York.

“UVM Health Advantage delivers a completely new Medicare Advantage experience – one that’s simpler, easier to use, and designed with our members and their physicians,” said MVP Health Care’s president and Chief Executive Officer, Christopher Del Vecchio. “We’re proud to pioneer this vision in partnership with UVM Health Network, which offers bold options for fighting two wide-spread conditions that older adults are facing.”

According to the CDC, heart disease is the leading cause of death in New York and Vermont, which is why UVM Health Advantage is supporting older adults as they navigate their health journey against this condition. Cardiac rehab level 3, which is designed to maintain a healthier lifestyle through supervised exercise sessions and health education, is covered at no cost — one of only three insurance plans in the country to so. Additionally, studies have shown the link between good dental hygiene and cardiac care — which is why UVM Health Advantage also offers robust dental benefits to its members.

Diabetes was also a top concern among older adults in the region, as more than 1.7 million New Yorkers and more than 55,000 Vermonters have been diagnosed with the condition. UVM Health Advantage covers routine podiatry visits, provides a glucometer and related supplies, includes low-cost orthotics and diabetic shoes, and free gym memberships to support in living a healthier lifestyle.

“We know that heart disease and diabetes can be successfully managed if patients have the right tools and support they need,” said John R. Brumsted, M.D., president and CEO of The University of Vermont Health Network. “We are excited about our partnership with MVP to offer a plan that can help older adults in our region live healthier lives.”

For more information: www.uvmhealthadvantage.com


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now